Sulfuric Acid

Sulfuric Acid

SCHEMBL783196

CCCCCCCCCCCC[n+]1ccccc1.O=S(=O)([O-])[O-].[H+]

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 4/20 0.74
CHRM2 P08172 2/20 0.74
ADRA2A P08913 2/20 0.74
ADORA3 P0DMS8 2/20 0.74
CHRM1 P11229 2/20 0.74
SLC6A2 P23975 2/20 0.74
SLC6A4 P31645 2/20 0.74
SLC6A3 Q01959 2/20 0.74
ABCB11 O95342 1/20 0.74
ESR1 P03372 1/20 0.74
PGR P06401 1/20 0.74
HTR1A P08908 1/20 0.74
DRD1 P21728 1/20 0.74
TBXA2R P21731 1/20 0.74
PTGS1 P23219 1/20 0.74
PDE4A P27815 1/20 0.74
ADRA1A P35348 1/20 0.74
OPRM1 P35372 1/20 0.74
DRD3 P35462 1/20 0.74
KCNH2 Q12809 1/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cetylpyridinium SCHEMBL782220 1.00 ACHE (0.74) ACHECHRM2ADRA2AADORA3CHRM1
Sulfuric Acid SCHEMBL11121738 0.98 ACHE (0.77) ACHECHRM2ADRA2AADORA3CHRM1
Cetylpyridinium SCHEMBL167608 0.98 ACHE (0.77) ACHECHRM2ADRA2AADORA3CHRM1
Sulfuric Acid SCHEMBL165670 0.98 ACHE (0.77) ACHECHRM2ADRA2AADORA3CHRM1
Sulfuric Acid SCHEMBL28100312 0.98 ACHE (0.77) ACHECHRM2ADRA2AADORA3CHRM1
Sulfuric Acid SCHEMBL9784616 0.98 ACHE (0.77) ACHECHRM2ADRA2AADORA3CHRM1
Sulfuric Acid SCHEMBL9784492 0.98 ACHE (0.77) ACHECHRM2ADRA2AADORA3CHRM1
SCHEMBL29251688 0.93 ACHE (0.74) ACHECHRM2ADRA2AADORA3CHRM1
SCHEMBL30212763 0.93 ACHE (0.74) ACHECHRM2ADRA2AADORA3CHRM1
SCHEMBL29252400 0.93 ACHE (0.74) ACHECHRM2ADRA2AADORA3CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2351728-B1 PROCESS FOR PRODUCING AN AROMATIC ALDEHYDE COMPOUND UBE INDUSTRIES (JP) 2015-01-07 EP disclosed
US-8618335-B2 Process for preparing aromatic aldehyde compound UBE INDUSTRIES LTD. (JP) 2013-12-31 US disclosed
US-20120071672-A1 PROCESS FOR PREPARING AROMATIC ALDEHYDE COMPOUND UBE CORPORATION (JP) 2012-03-22 US disclosed
EP-2351728-A1 PROCESS FOR PRODUCING AN AROMATIC ALDEHYDE COMPOUND Ube Industries, Ltd. (JP) 2011-08-03 EP disclosed
EP-0950659-B1 Process for producing 1,2-Epoxy-5,9-Cyclododecadiene UBE INDUSTRIES (JP) 2003-11-26 EP disclosed
US-6043383-A EPOXIDIZING 1,5,9-CYCLODODECATRIENE IN A CONTINUOUS MULTI-STAGE OXIDATION APPARATUS HAVING A PLURALITY OF REACTORS CONNECTED TO EACH OTHER USING HYDROGEN PEROXIDE AND OPTIONALLY A MINERAL ACID UBE INDUSTRIES, LTD. (JP) 2000-03-28 US disclosed
EP-0950659-A2 Proces for producing 1,2-Epoxy-5, 9-Cyclododecadiene Ube Industries, Ltd. (JP) 1999-10-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071672-A1 PROCESS FOR PREPARING AROMATIC ALDEHYDE COMPOUND AOX1, ADH5, AOC2 ACHE 2280/4885CHRM2 1117/4885ADRA2A 3447/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.